Publication | Closed Access

Exosome-mediated delivery of transforming growth factor-β receptor 1 kinase inhibitors and toll-like receptor 7/8 agonists for combination therapy of tumors

MedicineImmunologyTargeted Drug DeliveryKinase InhibitorsCombination TherapyExosome-mediated DeliveryTumor TargetingOncologyCell BiologyCancer ResearchNovel TherapyTumor BiologyCancer Growth